Section

Value Investing

Quarterly filings, cash-flow valuation, and long-term business analysis.

Latest news

Value Investing · Today's briefing

Edwards Lifesciences: Premium Multiple on a Structural-Heart Leader

Edwards Lifesciences posted Q2 2026 revenue of $1.741B and operating cash flow of $651.9M, continuing double-digit top-l...

Read →
News illustration: Edwards Lifesciences: Premium Multiple on a Structural-Heart Leader

Latest news

All →